Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine in Acute Stroke "TRUST"

Completed

Phase 3 Results

Summary of Purpose

To determine the value of oral nimodipine 120 mg per day for acute stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, double-blind, placebo-controlled multicenter study of 1215 patients at 17 British centers.

Contacts

Not available